As of 2025-07-07, the EV/EBITDA ratio of Moberg Pharma AB (publ) (MOB.ST) is -8.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MOB.ST's latest enterprise value is 165.54 mil SEK. MOB.ST's TTM EBITDA according to its financial statements is -19.68 mil SEK. Dividing these 2 quantities gives us the above MOB.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 12.4x | 6.8x |
| Forward P/E multiples | 5.2x - 7.9x | 6.5x |
| Fair Price | 3.39 - 2.29 | 2.82 |
| Upside | -62.3% - -74.5% | -68.7% |
| Date | EV/EBITDA |
| 2025-07-03 | -8.75 |
| 2025-07-02 | -8.58 |
| 2025-07-01 | -8.02 |
| 2025-06-30 | -8.72 |
| 2025-06-27 | -8.07 |
| 2025-06-26 | -7.78 |
| 2025-06-25 | -7.54 |
| 2025-06-24 | -6.53 |
| 2025-06-23 | -6.19 |
| 2025-06-19 | -7.33 |
| 2025-06-18 | -7.60 |
| 2025-06-17 | -7.89 |
| 2025-06-16 | -7.65 |
| 2025-06-13 | -6.42 |
| 2025-06-12 | -7.03 |
| 2025-06-11 | -7.16 |
| 2025-06-10 | -7.22 |
| 2025-06-09 | -7.51 |
| 2025-06-05 | -8.35 |
| 2025-06-04 | -8.96 |
| 2025-06-03 | -8.61 |
| 2025-06-02 | -9.24 |
| 2025-05-30 | -9.30 |
| 2025-05-28 | -9.23 |
| 2025-05-27 | -9.03 |
| 2025-05-26 | -8.66 |
| 2025-05-23 | -7.68 |
| 2025-05-22 | -7.03 |
| 2025-05-21 | -7.96 |
| 2025-05-20 | -6.56 |
| 2025-05-19 | -6.94 |
| 2025-05-16 | -7.38 |
| 2025-05-15 | -6.76 |
| 2025-05-14 | -6.33 |
| 2025-05-13 | -4.90 |
| 2025-05-12 | -4.41 |
| 2025-05-09 | -4.53 |
| 2025-05-08 | -4.36 |
| 2025-05-07 | -4.62 |
| 2025-05-06 | -4.60 |
| 2025-05-05 | -5.14 |
| 2025-05-02 | -5.59 |
| 2025-04-30 | -5.63 |
| 2025-04-29 | -5.26 |
| 2025-04-28 | -5.75 |
| 2025-04-25 | -6.25 |
| 2025-04-24 | -5.77 |
| 2025-04-23 | -6.26 |
| 2025-04-22 | -5.74 |
| 2025-04-17 | -5.26 |